Global Autoimmune Disease Diagnostics Market Insights, Forecast to 2028

  • Report ID:245359
  • Industry Name: Pharma & Healthcare
  • Publishing Date: Jul-22
  • No. of Pages: 127
                              
Autoimmune Disease Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Analyzers Assay Kits Segment by Application Hospitals Research Laboratories By Company Abbott Laboratories Beckman Coulter Bio-Rad Laboratories EUROIMMUN Inova Diagnostics Roche Diagnostics Siemens Healthcare DiaSorin ERBA Diagnostics Euro Diagnostica Autoimmune Technologies Avant Diagnostics Exagen Diagnostics Gold Standard Diagnostics HOB Diagnostics HUMAN Diagnostics Immco Diagnostics ImmunArray Myriad Genetics Omega Diagnostics ORGENTEC Diagnostika Phadia Protagen By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Analyzers 1.2.3 Assay Kits 1.3 Market by Application 1.3.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospitals 1.3.3 Research Laboratories 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Autoimmune Disease Diagnostics Market Perspective (2017-2028) 2.2 Autoimmune Disease Diagnostics Growth Trends by Region 2.2.1 Autoimmune Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Autoimmune Disease Diagnostics Historic Market Size by Region (2017-2022) 2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Region (2023-2028) 2.3 Autoimmune Disease Diagnostics Market Dynamics 2.3.1 Autoimmune Disease Diagnostics Industry Trends 2.3.2 Autoimmune Disease Diagnostics Market Drivers 2.3.3 Autoimmune Disease Diagnostics Market Challenges 2.3.4 Autoimmune Disease Diagnostics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Autoimmune Disease Diagnostics Players by Revenue 3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2017-2022) 3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2017-2022) 3.2 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue 3.4 Global Autoimmune Disease Diagnostics Market Concentration Ratio 3.4.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2021 3.5 Autoimmune Disease Diagnostics Key Players Head office and Area Served 3.6 Key Players Autoimmune Disease Diagnostics Product Solution and Service 3.7 Date of Enter into Autoimmune Disease Diagnostics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Autoimmune Disease Diagnostics Breakdown Data by Type 4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2017-2022) 4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2023-2028) 5 Autoimmune Disease Diagnostics Breakdown Data by Application 5.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2017-2022) 5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Autoimmune Disease Diagnostics Market Size (2017-2028) 6.2 North America Autoimmune Disease Diagnostics Market Size by Type 6.2.1 North America Autoimmune Disease Diagnostics Market Size by Type (2017-2022) 6.2.2 North America Autoimmune Disease Diagnostics Market Size by Type (2023-2028) 6.2.3 North America Autoimmune Disease Diagnostics Market Share by Type (2017-2028) 6.3 North America Autoimmune Disease Diagnostics Market Size by Application 6.3.1 North America Autoimmune Disease Diagnostics Market Size by Application (2017-2022) 6.3.2 North America Autoimmune Disease Diagnostics Market Size by Application (2023-2028) 6.3.3 North America Autoimmune Disease Diagnostics Market Share by Application (2017-2028) 6.4 North America Autoimmune Disease Diagnostics Market Size by Country 6.4.1 North America Autoimmune Disease Diagnostics Market Size by Country (2017-2022) 6.4.2 North America Autoimmune Disease Diagnostics Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Autoimmune Disease Diagnostics Market Size (2017-2028) 7.2 Europe Autoimmune Disease Diagnostics Market Size by Type 7.2.1 Europe Autoimmune Disease Diagnostics Market Size by Type (2017-2022) 7.2.2 Europe Autoimmune Disease Diagnostics Market Size by Type (2023-2028) 7.2.3 Europe Autoimmune Disease Diagnostics Market Share by Type (2017-2028) 7.3 Europe Autoimmune Disease Diagnostics Market Size by Application 7.3.1 Europe Autoimmune Disease Diagnostics Market Size by Application (2017-2022) 7.3.2 Europe Autoimmune Disease Diagnostics Market Size by Application (2023-2028) 7.3.3 Europe Autoimmune Disease Diagnostics Market Share by Application (2017-2028) 7.4 Europe Autoimmune Disease Diagnostics Market Size by Country 7.4.1 Europe Autoimmune Disease Diagnostics Market Size by Country (2017-2022) 7.4.2 Europe Autoimmune Disease Diagnostics Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2017-2028) 8.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type 8.2.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Autoimmune Disease Diagnostics Market Share by Type (2017-2028) 8.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application 8.3.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Autoimmune Disease Diagnostics Market Share by Application (2017-2028) 8.4 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region 8.4.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Autoimmune Disease Diagnostics Market Size (2017-2028) 9.2 Latin America Autoimmune Disease Diagnostics Market Size by Type 9.2.1 Latin America Autoimmune Disease Diagnostics Market Size by Type (2017-2022) 9.2.2 Latin America Autoimmune Disease Diagnostics Market Size by Type (2023-2028) 9.2.3 Latin America Autoimmune Disease Diagnostics Market Share by Type (2017-2028) 9.3 Latin America Autoimmune Disease Diagnostics Market Size by Application 9.3.1 Latin America Autoimmune Disease Diagnostics Market Size by Application (2017-2022) 9.3.2 Latin America Autoimmune Disease Diagnostics Market Size by Application (2023-2028) 9.3.3 Latin America Autoimmune Disease Diagnostics Market Share by Application (2017-2028) 9.4 Latin America Autoimmune Disease Diagnostics Market Size by Country 9.4.1 Latin America Autoimmune Disease Diagnostics Market Size by Country (2017-2022) 9.4.2 Latin America Autoimmune Disease Diagnostics Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2017-2028) 10.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type 10.2.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Autoimmune Disease Diagnostics Market Share by Type (2017-2028) 10.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application 10.3.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Autoimmune Disease Diagnostics Market Share by Application (2017-2028) 10.4 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country 10.4.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction 11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.1.5 Abbott Laboratories Recent Developments 11.2 Beckman Coulter 11.2.1 Beckman Coulter Company Details 11.2.2 Beckman Coulter Business Overview 11.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction 11.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.2.5 Beckman Coulter Recent Developments 11.3 Bio-Rad Laboratories 11.3.1 Bio-Rad Laboratories Company Details 11.3.2 Bio-Rad Laboratories Business Overview 11.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction 11.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.3.5 Bio-Rad Laboratories Recent Developments 11.4 EUROIMMUN 11.4.1 EUROIMMUN Company Details 11.4.2 EUROIMMUN Business Overview 11.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction 11.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.4.5 EUROIMMUN Recent Developments 11.5 Inova Diagnostics 11.5.1 Inova Diagnostics Company Details 11.5.2 Inova Diagnostics Business Overview 11.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction 11.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.5.5 Inova Diagnostics Recent Developments 11.6 Roche Diagnostics 11.6.1 Roche Diagnostics Company Details 11.6.2 Roche Diagnostics Business Overview 11.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction 11.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.6.5 Roche Diagnostics Recent Developments 11.7 Siemens Healthcare 11.7.1 Siemens Healthcare Company Details 11.7.2 Siemens Healthcare Business Overview 11.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction 11.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.7.5 Siemens Healthcare Recent Developments 11.8 DiaSorin 11.8.1 DiaSorin Company Details 11.8.2 DiaSorin Business Overview 11.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction 11.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.8.5 DiaSorin Recent Developments 11.9 ERBA Diagnostics 11.9.1 ERBA Diagnostics Company Details 11.9.2 ERBA Diagnostics Business Overview 11.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction 11.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.9.5 ERBA Diagnostics Recent Developments 11.10 Euro Diagnostica 11.10.1 Euro Diagnostica Company Details 11.10.2 Euro Diagnostica Business Overview 11.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction 11.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.10.5 Euro Diagnostica Recent Developments 11.11 Autoimmune Technologies 11.11.1 Autoimmune Technologies Company Details 11.11.2 Autoimmune Technologies Business Overview 11.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction 11.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.11.5 Autoimmune Technologies Recent Developments 11.12 Avant Diagnostics 11.12.1 Avant Diagnostics Company Details 11.12.2 Avant Diagnostics Business Overview 11.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction 11.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.12.5 Avant Diagnostics Recent Developments 11.13 Exagen Diagnostics 11.13.1 Exagen Diagnostics Company Details 11.13.2 Exagen Diagnostics Business Overview 11.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction 11.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.13.5 Exagen Diagnostics Recent Developments 11.14 Gold Standard Diagnostics 11.14.1 Gold Standard Diagnostics Company Details 11.14.2 Gold Standard Diagnostics Business Overview 11.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction 11.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.14.5 Gold Standard Diagnostics Recent Developments 11.15 HOB Diagnostics 11.15.1 HOB Diagnostics Company Details 11.15.2 HOB Diagnostics Business Overview 11.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction 11.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.15.5 HOB Diagnostics Recent Developments 11.16 HUMAN Diagnostics 11.16.1 HUMAN Diagnostics Company Details 11.16.2 HUMAN Diagnostics Business Overview 11.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction 11.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.16.5 HUMAN Diagnostics Recent Developments 11.17 Immco Diagnostics 11.17.1 Immco Diagnostics Company Details 11.17.2 Immco Diagnostics Business Overview 11.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction 11.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.17.5 Immco Diagnostics Recent Developments 11.18 ImmunArray 11.18.1 ImmunArray Company Details 11.18.2 ImmunArray Business Overview 11.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction 11.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.18.5 ImmunArray Recent Developments 11.19 Myriad Genetics 11.19.1 Myriad Genetics Company Details 11.19.2 Myriad Genetics Business Overview 11.19.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction 11.19.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.19.5 Myriad Genetics Recent Developments 11.20 Omega Diagnostics 11.20.1 Omega Diagnostics Company Details 11.20.2 Omega Diagnostics Business Overview 11.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction 11.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.20.5 Omega Diagnostics Recent Developments 11.21 ORGENTEC Diagnostika 11.21.1 ORGENTEC Diagnostika Company Details 11.21.2 ORGENTEC Diagnostika Business Overview 11.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction 11.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.21.5 ORGENTEC Diagnostika Recent Developments 11.22 Phadia 11.22.1 Phadia Company Details 11.22.2 Phadia Business Overview 11.22.3 Phadia Autoimmune Disease Diagnostics Introduction 11.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.22.5 Phadia Recent Developments 11.23 Protagen 11.23.1 Protagen Company Details 11.23.2 Protagen Business Overview 11.23.3 Protagen Autoimmune Disease Diagnostics Introduction 11.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2017-2022) 11.23.5 Protagen Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Analyzers Table 3. Key Players of Assay Kits Table 4. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global Autoimmune Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Autoimmune Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million) Table 7. Global Autoimmune Disease Diagnostics Market Share by Region (2017-2022) Table 8. Global Autoimmune Disease Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global Autoimmune Disease Diagnostics Market Share by Region (2023-2028) Table 10. Autoimmune Disease Diagnostics Market Trends Table 11. Autoimmune Disease Diagnostics Market Drivers Table 12. Autoimmune Disease Diagnostics Market Challenges Table 13. Autoimmune Disease Diagnostics Market Restraints Table 14. Global Autoimmune Disease Diagnostics Revenue by Players (2017-2022) & (US$ Million) Table 15. Global Autoimmune Disease Diagnostics Revenue Share by Players (2017-2022) Table 16. Global Top Autoimmune Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnostics as of 2021) Table 17. Ranking of Global Top Autoimmune Disease Diagnostics Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by Autoimmune Disease Diagnostics Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Autoimmune Disease Diagnostics Product Solution and Service Table 21. Date of Enter into Autoimmune Disease Diagnostics Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Autoimmune Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 24. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2017-2022) Table 25. Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2023-2028) Table 27. Global Autoimmune Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 28. Global Autoimmune Disease Diagnostics Revenue Share by Application (2017-2022) Table 29. Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global Autoimmune Disease Diagnostics Revenue Share by Application (2023-2028) Table 31. North America Autoimmune Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 32. North America Autoimmune Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 33. North America Autoimmune Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 34. North America Autoimmune Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 35. North America Autoimmune Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 36. North America Autoimmune Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe Autoimmune Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe Autoimmune Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe Autoimmune Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe Autoimmune Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe Autoimmune Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe Autoimmune Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific Autoimmune Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific Autoimmune Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific Autoimmune Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific Autoimmune Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific Autoimmune Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific Autoimmune Disease Diagnostics Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America Autoimmune Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America Autoimmune Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America Autoimmune Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America Autoimmune Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America Autoimmune Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America Autoimmune Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa Autoimmune Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa Autoimmune Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa Autoimmune Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa Autoimmune Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa Autoimmune Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa Autoimmune Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million) Table 61. Abbott Laboratories Company Details Table 62. Abbott Laboratories Business Overview Table 63. Abbott Laboratories Autoimmune Disease Diagnostics Product Table 64. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 65. Abbott Laboratories Recent Developments Table 66. Beckman Coulter Company Details Table 67. Beckman Coulter Business Overview Table 68. Beckman Coulter Autoimmune Disease Diagnostics Product Table 69. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 70. Beckman Coulter Recent Developments Table 71. Bio-Rad Laboratories Company Details Table 72. Bio-Rad Laboratories Business Overview Table 73. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product Table 74. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 75. Bio-Rad Laboratories Recent Developments Table 76. EUROIMMUN Company Details Table 77. EUROIMMUN Business Overview Table 78. EUROIMMUN Autoimmune Disease Diagnostics Product Table 79. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 80. EUROIMMUN Recent Developments Table 81. Inova Diagnostics Company Details Table 82. Inova Diagnostics Business Overview Table 83. Inova Diagnostics Autoimmune Disease Diagnostics Product Table 84. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 85. Inova Diagnostics Recent Developments Table 86. Roche Diagnostics Company Details Table 87. Roche Diagnostics Business Overview Table 88. Roche Diagnostics Autoimmune Disease Diagnostics Product Table 89. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 90. Roche Diagnostics Recent Developments Table 91. Siemens Healthcare Company Details Table 92. Siemens Healthcare Business Overview Table 93. Siemens Healthcare Autoimmune Disease Diagnostics Product Table 94. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 95. Siemens Healthcare Recent Developments Table 96. DiaSorin Company Details Table 97. DiaSorin Business Overview Table 98. DiaSorin Autoimmune Disease Diagnostics Product Table 99. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 100. DiaSorin Recent Developments Table 101. ERBA Diagnostics Company Details Table 102. ERBA Diagnostics Business Overview Table 103. ERBA Diagnostics Autoimmune Disease Diagnostics Product Table 104. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 105. ERBA Diagnostics Recent Developments Table 106. Euro Diagnostica Company Details Table 107. Euro Diagnostica Business Overview Table 108. Euro Diagnostica Autoimmune Disease Diagnostics Product Table 109. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 110. Euro Diagnostica Recent Developments Table 111. Autoimmune Technologies Company Details Table 112. Autoimmune Technologies Business Overview Table 113. Autoimmune Technologies Autoimmune Disease Diagnostics Product Table 114. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 115. Autoimmune Technologies Recent Developments Table 116. Avant Diagnostics Company Details Table 117. Avant Diagnostics Business Overview Table 118. Avant Diagnostics Autoimmune Disease Diagnostics Product Table 119. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 120. Avant Diagnostics Recent Developments Table 121. Exagen Diagnostics Company Details Table 122. Exagen Diagnostics Business Overview Table 123. Exagen Diagnostics Autoimmune Disease Diagnostics Product Table 124. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 125. Exagen Diagnostics Recent Developments Table 126. Gold Standard Diagnostics Company Details Table 127. Gold Standard Diagnostics Business Overview Table 128. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product Table 129. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 130. Gold Standard Diagnostics Recent Developments Table 131. HOB Diagnostics Company Details Table 132. HOB Diagnostics Business Overview Table 133. HOB Diagnostics Autoimmune Disease Diagnostics Product Table 134. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 135. HOB Diagnostics Recent Developments Table 136. HUMAN Diagnostics Company Details Table 137. HUMAN Diagnostics Business Overview Table 138. HUMAN Diagnostics Autoimmune Disease Diagnostics Product Table 139. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 140. HUMAN Diagnostics Recent Developments Table 141. Immco Diagnostics Company Details Table 142. Immco Diagnostics Business Overview Table 143. Immco Diagnostics Autoimmune Disease Diagnostics Product Table 144. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 145. Immco Diagnostics Recent Developments Table 146. ImmunArray Company Details Table 147. ImmunArray Business Overview Table 148. ImmunArray Autoimmune Disease Diagnostics Product Table 149. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 150. ImmunArray Recent Developments Table 151. Myriad Genetics Company Details Table 152. Myriad Genetics Business Overview Table 153. Myriad Genetics Autoimmune Disease Diagnostics Product Table 154. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 155. Myriad Genetics Recent Developments Table 156. Omega Diagnostics Company Details Table 157. Omega Diagnostics Business Overview Table 158. Omega Diagnostics Autoimmune Disease Diagnostics Product Table 159. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 160. Omega Diagnostics Recent Developments Table 161. ORGENTEC Diagnostika Company Details Table 162. ORGENTEC Diagnostika Business Overview Table 163. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product Table 164. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 165. ORGENTEC Diagnostika Recent Developments Table 166. Phadia Company Details Table 167. Phadia Business Overview Table 168. Phadia Autoimmune Disease Diagnostics Product Table 169. Phadia Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 170. Phadia Recent Developments Table 171. Protagen Company Details Table 172. Protagen Business Overview Table 173. Protagen Autoimmune Disease Diagnostics Product Table 174. Protagen Revenue in Autoimmune Disease Diagnostics Business (2017-2022) & (US$ Million) Table 175. Protagen Recent Developments Table 176. Research Programs/Design for This Report Table 177. Key Data Information from Secondary Sources Table 178. Key Data Information from Primary Sources List of Figures Figure 1. Global Autoimmune Disease Diagnostics Market Share by Type: 2021 VS 2028 Figure 2. Analyzers Features Figure 3. Assay Kits Features Figure 4. Global Autoimmune Disease Diagnostics Market Share by Application: 2021 VS 2028 Figure 5. Hospitals Case Studies Figure 6. Research Laboratories Case Studies Figure 7. Autoimmune Disease Diagnostics Report Years Considered Figure 8. Global Autoimmune Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global Autoimmune Disease Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Autoimmune Disease Diagnostics Market Share by Region: 2021 VS 2028 Figure 11. Global Autoimmune Disease Diagnostics Market Share by Players in 2021 Figure 12. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Diagnostics as of 2021) Figure 13. The Top 10 and 5 Players Market Share by Autoimmune Disease Diagnostics Revenue in 2021 Figure 14. North America Autoimmune Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America Autoimmune Disease Diagnostics Market Size Market Share by Type (2017-2028) Figure 16. North America Autoimmune Disease Diagnostics Market Size Market Share by Application (2017-2028) Figure 17. North America Autoimmune Disease Diagnostics Market Size Share by Country (2017-2028) Figure 18. United States Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Autoimmune Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe Autoimmune Disease Diagnostics Market Size Market Share by Type (2017-2028) Figure 22. Europe Autoimmune Disease Diagnostics Market Size Market Share by Application (2017-2028) Figure 23. Europe Autoimmune Disease Diagnostics Market Size Share by Country (2017-2028) Figure 24. Germany Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Autoimmune Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific Autoimmune Disease Diagnostics Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific Autoimmune Disease Diagnostics Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific Autoimmune Disease Diagnostics Market Size Share by Region (2017-2028) Figure 34. China Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America Autoimmune Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America Autoimmune Disease Diagnostics Market Size Market Share by Type (2017-2028) Figure 42. Latin America Autoimmune Disease Diagnostics Market Size Market Share by Application (2017-2028) Figure 43. Latin America Autoimmune Disease Diagnostics Market Size Share by Country (2017-2028) Figure 44. Mexico Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa Autoimmune Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa Autoimmune Disease Diagnostics Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa Autoimmune Disease Diagnostics Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa Autoimmune Disease Diagnostics Market Size Share by Country (2017-2028) Figure 50. Turkey Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE Autoimmune Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. Abbott Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 54. Beckman Coulter Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 55. Bio-Rad Laboratories Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 56. EUROIMMUN Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 57. Inova Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 58. Roche Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 59. Siemens Healthcare Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 60. DiaSorin Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 61. ERBA Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 62. Euro Diagnostica Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 63. Autoimmune Technologies Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 64. Avant Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 65. Exagen Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 66. Gold Standard Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 67. HOB Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 68. HUMAN Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 69. Immco Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 70. ImmunArray Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 71. Myriad Genetics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 72. Omega Diagnostics Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 73. ORGENTEC Diagnostika Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 74. Phadia Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 75. Protagen Revenue Growth Rate in Autoimmune Disease Diagnostics Business (2017-2022) Figure 76. Bottom-up and Top-down Approaches for This Report Figure 77. Data Triangulation Figure 78. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.